FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/07/2026
Voltar para busca
Dado oficial do USPTO
QUBIT PHARMACEUTICALS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
37
Atualização mais recente
07/07/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
9, 35, 38, 42
Data de depósito
22/04/2024
Data de registro
07/04/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/04/2026
Última transação
07/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
34
Localização do titular
FR
Examinador
KLUWE, CHERYL D
Unidade examinadora
N80
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the wording "QUBIT PHARMACEUTICALS" in stylized font placed to the left of a stylized cross design.
Titulares e representantes
Titulares
Q. P. (pessoa física)
Representantes
STEVEN J SOLOMON TUCKER ELLIS LLP
Classificação técnica
Classes Nice
Classe 9Classe 35Classe 38Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable and recorded computer software using artificial intelligence for visualization and modeling of moleculesmolecular interactionsdrug discoverysimulation of drug-target bindingfor the analysis of biomedical datasets; data acquisition and processing apparatus;; downloadable applications for mobile devices for visualization and modeling of moleculesmolecular interactionsdrug discoverysimulation of drug-target bindingfor the analysis of biomedical datasets; electronic databases recorded on computer media for use in the fields of cosmeticshealthmedicinepharmacology and the treatment of illnesses; data files in electronic formatdownloadablenamely data sets containing data concerning cosmeticshealthmedicinepharmacology and the treatment of illnesses; scientifictechnological and educational data sets in electronic formdownloadable; downloadable soundvideo and audiovisual recordings featuring scientifictechnological and educational information in the fields of cosmeticshealthmedicinepharmacology and the treatment of illnesses; downloadable and recorded software for conducting research; downloadable and recorded artificial intelligence and machine learning software for conducting scientific research in the cosmetic and medical fields; downloadable and recorded software for streaming scientific and technological content via the Internet and global communication networks; downloadable and recorded software for disseminating scientific and technological content to mobile digital electronic devices; downloadable and recorded scientific intelligence and monitoring software for visualization and modeling of moleculesmolecular interactionsdrug discoverysimulation of drug-target bindingfor the analysis of biomedical datasets; downloadable and recorded software for scientific and technological data research; downloadable computer software and applications using artificial intelligencemachine learningdeep learningreinforcement learning for use in the development of pharmaceuticals; downloadable and recorded computer softwarecomputer programs featuring algorithms for manipulating data input or received; data processing equipment; downloadable and recorded software for decision-making support; downloadable and recorded software for data analysis in the fields of cosmeticshealthmedicinepharmacology and the treatment of illnesses; downloadable and recorded software for data aggregationanalysis and processing integrating a collective work environment and for shared work and shared use of resources and data; downloadable and recorded software for planningperformingintegratingoptimizing and monitoring the research and development of new productsparticularly new drugs; downloadable and recorded computer simulation software for planningperformanceintegrationoptimization and tracking of research and development of new productsparticularly new drugs; downloadable and recorded collaborative software platforms for collaboration managementparticularly in the scientific and technical fields; downloadable electronic publicationsresearch articlesscientific journalswhite papersreportsconference proceedings featuring quantum computing applicationsartificial intelligence (AI) methodologies for research; all of the aforesaid goods being for use in connection with or relating to scientific research and research in the medical and pharmaceutical fields.
Classe 35
Collection of informationparticularly commercial and scientific informationcompilation of scientificcosmetichealthmedical and pharmacology information into computer databases for business purposes; collection of datacommercialscientificcosmetic and health datafor business purposes; Providing consumer product information to customers via the Internet; computerized database management; management of computerized files and records of molecules and formulations for medical and pharmaceutical useas well as medicines and medical and pharmaceutical research; provision of business information services relating to data processing; providing commercial information from on-line databases; organization of business meetingsbusiness meeting planning for establishing commercial collaborations; computer data processing services; compilation of statistical data relating to medical research for business purposes; business networking servicesarranging and commercial management of business collaborations; business project management with respect to commercial businessfeaturing business research and business development collaborations; compilation of scientific and technical information into computer databases; business information and advice concerning all the aforesaid services; all the aforesaid services provided in connection with or relating to scientific research and the pharmaceutical and medical fields.
Classe 38
Transmission of information and data by electronic communication networks; rental of access time to users of computer programs on data networks; rental of access time to platforms on the Internet enabling the consultationanalysisexchange and sharing of data; rental of access time to databases in global computer networks; all the aforesaid services provided in connection with or relating to scientific research and the pharmaceutical and medical field.
Classe 42
Scientific research and scientific analysis of molecules in the field of developing cosmetics and treatments and medicines; medical research servicescomputerized testing and analysis of medical compoundsmedicines and molecules with the purpose of discovering new treatments or improving and optimizing of existing treatments; design of technical and scientific studiesdesignplanning of scientific research studies; designdevelopmentprogrammingconfigurationinstallationmaintenanceupdating and testing of algorithms and computer softwareparticularly for artificial intelligencemolecular modelling and molecular interactions modelingdecision support; designdevelopmentprogrammingconfigurationinstallationmaintenanceupdating and testing of algorithms and computer software and platforms that are used for consultinganalyzingexchanging and sharing dataparticularly in a collaborative work environmentfor use in the fields of cosmeticshealthmedicinepharmacology and the treatment of illnesses; designdevelopmentcompositionupdating and testing of new medicines and new medicine formulas all being scientific research; medical and scientific research for the development of pharmaceutical products for medical or veterinary use; computer database design and developmentdesigning databases for use in the fields of healthmedicinepharmacology and the treatment of illnesses; design of computer databases; development of computer platforms; scientific and technical project study being scientific study and research in the fields of medicinepharmacology and the treatment of illnesses; conducting of engineering surveys; designdevelopment and programming of artificial intelligence software for use in the fields of healthmedicinepharmacology and the treatment of illnesses; software design and development for data captureinputextractionprocessingdisplay and storage systems; consultancy in connection with computer technology; development of computer programsdecision support software; Software as a Service (SaaS) services featuring software for processing and analyzing data in the fields of healthmedicinepharmacology and the treatment of illnesses; computer project management in the field of electronic data processing; hosting of digital contentof computer databasesfor othersin the fields of cosmetichealthmedicinepharmacology and the treatment of illnesses; rental of computer software in the fields of cosmetichealthmedicinepharmacology and the treatment of illnesses; platform as a service (PaaS) featuring computer software platforms for high performance or quantum computingfor pharmaceuticalmedical and scientific research; provision of information relating to scientific technologynamely scientific research information in the field of pharmaceuticals; provision of temporary use of non-downloadable software for data processing and analysis; preparation of technical and scientific reportsproviding technical and scientific information in the field of medical research; scientific research services; research and development services relating to the processing of medical data for third parties; computer programming services for data analysis; pharmaceutical and drug active ingredient discovery services; organizingcoordinatingconducting and monitoring scientific research in the field of cosmeticshealthmedicinepharmacology and the treatment of illnesses; advanced product researchdesign and development in the field of artificial intelligence; research in the field of quantum computing services applied to pharmaceuticalmedical and scientific research; compiling data for scientific research purposes in the pharmaceutical and medical fields; drug discovery services; advisory and information services relating to the aforesaid services; all the aforesaid services provided in connection with or relating to scientific research and the medical field.
Publicações
Histórico de despachos e eventos da marca no USPTO.
37 publicações encontradas
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/04/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
07/04/2026
TMBN
TTAB RELEASE CASE TO TRADEMARKS
18/03/2026
OP.T
OPPOSITION TERMINATED NO. 999999
18/03/2026
OP.S
OPPOSITION SUSTAINED NO. 999999
18/03/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/02/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/01/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
27/01/2026
RFNP
REFUSAL PROCESSED BY IB
05/12/2025
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
08/11/2025
OP.I
OPPOSITION INSTITUTED NO. 999999
07/11/2025
OPNS
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
06/11/2025
OPNC
OPPOSITION NOTICE (IB REFUSAL) CREATED
06/11/2025
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
30/07/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/07/2025
PUBO
PUBLISHED FOR OPPOSITION
08/07/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/07/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/06/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/05/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/05/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/05/2025
DOCK
ASSIGNED TO EXAMINER
03/04/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/03/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/03/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/03/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
14/03/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
14/03/2025
RFNT
REFUSAL PROCESSED BY IB
29/12/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/12/2024
RFRR
REFUSAL PROCESSED BY MPU
06/12/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
22/11/2024
CNRT
NON-FINAL ACTION WRITTEN
21/11/2024
DOCK
ASSIGNED TO EXAMINER
04/11/2024
MAFR
APPLICATION FILING RECEIPT MAILED
03/09/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/09/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
29/08/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace QUBIT PHARMACEUTICALS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.